Badanie metabolitów w osoczu krwi ujawnia zmiany metaboliczne związane z idiopatyczną epilepsją u psów
Untargeted Plasma Metabolomics Reveals Metabolic Alterations Associated With Idiopathic Epilepsy in Dogs
W skrócie
Badacze zbadali zmianę składu chemicznego krwi u psów chorych na epilepsję idiopatyczną (której przyczyny nie można ustalić). Znaleźli różnice w metabolitach (substancjach chemicznych powstających w organizmie) między zdrowymi psami, psami podczas ataku padaczki i psami które były wolne od ataków przez 14 dni po leczeniu. Wyniki są wstępne i pokazują, że zmiany chemiczne w krwi mogą być związane z epilepsją, ale potrzebne są dalsze badania na większej liczbie zwierząt.
Oryginalny abstract (angielski)
BACKGROUND: Canine idiopathic epilepsy (IE) is one of the most common chronic neurological disorders in dogs, however, its underlying pathophysiology remains incompletely understood. OBJECTIVES: This study aimed to characterise plasma metabolomic alterations associated with canine IE at two clinical points using an untargeted metabolomic approach. METHODS: Plasma samples were collected from nine client-owned healthy dogs (Normal), and nine dogs with idiopathic epilepsy evaluated at acute seizure state (Epilepsy_D0) and after a 14-day seizure-free interval following antiepileptic treatment (Epilepsy_D14). For metabolomic analysis, plasma from three dogs was pooled to generate three biological pools per condition. Untargeted plasma metabolomic profiling was performed using LC-QTOF-MS in positive ionisation mode. RESULTS: A total of 491 metabolites were retained for downstream analysis. Exploratory heatmap and principal component analyses showed differences in overall metabolic patterns among three groups. Differential abundance analysis identified distinct metabolite changes across the pairwise comparison. Pathway enrichment analysis of the significantly altered metabolites using the study-specific metabolite set as a custom background did not identify any pathway reaching statistical significance. Six metabolites of interest, namely pyridoxal, methylimidazoleacetic acid, 2-methylbutyroylcarnitine, indolelactic acid, homocitrulline and DL-Normetanephrine, showed distinct abundance patterns across the study conditions. CONCLUSIONS: These findings provide preliminary evidence of plasma metabolic alterations associated with canine IE and differences between the acute seizure state and the 14-day seizure-free interval. Given the pooled biological design and limited effective sample size, these findings should be considered exploratory and require validation in larger cohorts using individual biological samples.